Allergan Finance LLC 8-K 2013
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported)
January 24, 2013
(Exact Name of Registrant as Specified in Its Charter)
(Registrants telephone number, including area code)
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
(b) On January 24, 2013, Anthony Selwyn Tabatznik, who has served as a member of the Board of Directors of Actavis, Inc. (the Company) since December 2, 2009, notified the Company of his decision to resign from the Board, effective immediately. Mr. Tabatzniks decision was not the result of any disagreement with the Company, its management or the Board of Directors.
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.